Creatine monohydrate in myotonic dystrophy: A double-blind, placebo-controlled clinical study

Journal of Neurology

Volumn 249, Issue 12, 2002, Pages 1717-1722

  Walter, Maggie C ^b   Reilich, Peter ^b   Lochmüller, Hanns ^b   Kohnen, Ralph ^a   Schlotter, Beate ^b   Hautmann, Hubert ^b   Dunkl, Elmar ^a   Pongratz, Dieter ^b   Müller Felber, Wolfgang ^b  

^a IMEREM Inst Med Res Mgmt B   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Creatine monohydrate; Myotonic dystrophy (MD); Supplementation; Therapy

Indexed keywords

CREATINE; PLACEBO;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; HUMAN; MUSCLE STRENGTH; MYOTONIC DYSTROPHY; PRIORITY JOURNAL; SIDE EFFECT; TREATMENT OUTCOME;

ACTIVITIES OF DAILY LIVING; ADULT; CREATINE; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; MUSCLE WEAKNESS; MYOTONIC DYSTROPHY; STATISTICS, NONPARAMETRIC;

EID: 0344407002     PISSN: 03405354     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00415-002-0923-x     Document Type: Article

References (13)

1. Brook JD, Mc Currach ME, Harley HG, Buckler AJ, Church D, Aburatani H, Hunter K, Stanton VP, Thirion JP, Hudon T, et al. (1992) Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3′ end of a transcript encoding a protein kinase family member. Cell 68:799-808
2. Tarnopolsky MA, Martin J (1999) Creatine monohydrate increases strength in patients with neuromuscular disease. Neurology 52:854-857
3. Tarnopolsky MA, Roy BD, MacDonald JR (1997) A randomized, controlled trial of creatine monohydrate in patients with mitochondrial cytopathies. Muscle Nerve 20:1502-1509
4. Klopstock T, Querner V, Schmidt F, Gekeler F, Walter MC, Hartard M, Hennig M, Gasser T, Pongratz D, Straube A, Dieterich M, Müller-Felber, W (2000) Creatine monohydrate in mitochondrial diseases. A double-blind, placebo-controlled, cross-over study in 16 patients with chronic progressive external ophthalmoplegia or mitochondrial myopathy. Neurology 72:1748-1751
5. Vorgerd M, Grehl T, Jager M, Muller K, Freitag G, Patzold T, Bruns N, Fabian K, Tegenthoff M, Mortier W, Luttmann A, Zange J, Malin JP (2000) Creatine therapy in myophosphorylase deficiency (McArdle disease): a placebo-controlled crossover trial. Arch Neurol 57:956-963
6. Walter MC, Lochmuller H, Reilich P, Klopstock T, Huber R, Hartard M, Hennig M, Pongratz D, Muller-Felber W (2000) Creatine monohydrate in muscular dystrophies: A double-blind, placebo-controlled clinical study. Neurology 55:1748-1751
7. Scott OM, Hyde SA, Goddard C, Dubowitz V (1982) Quantitation of muscle function in children: a prospective study in Duchenne muscular dystrophy. Muscle Nerve 5:291-301
8. Lehmacher, W. 1987. Medizinische Informatik und Statistik Bd. 67, Berlin: Springer
9. Doherty TJ, Lougheed K, Markez J, Tarnopolsky MA (2001) Creatine monohydrate does not increase strength in patients with hereditary neuropathy. Neurology 57:559-560
10. Younkin DP, Berman P, Sladky J, Chee C, Bank W, Chance B (1987) 31P NMR studies in Duchenne muscular dystrophy: age-related metabolic changes. Neurology 37:165-169
11. Kemp GJ, Taylor DJ, Dunn JF, Frostick SP, Radda GK (1993) Cellular energetics of dystrophic muscle. J Neurol Sci 116:201-206
12. Barnes PRJ, Kemp GJ, Taylor DJ, Radda GK (1997) Skeletal muscle metabolism in myotonic dystrophy. Brain 120:1699-1711
13. Jowko E, Ostaszewski P, Jank M, Sacharuk J, Zieniewicz A, Wilczak J, Nissen S (2001) Creatine and beta-Hydroxy-beta-Methylbutyrate (HMB) additively increase lean body mass and muscle strength during a weight-training program. Nutrition 17:558-566